Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc gives FY, Q4 2013 charge guidance; Lowers FY 2013 GAAP EPS guidance


Wednesday, 19 Feb 2014 07:30am EST 

Endo Health Solutions Inc:Completes annual goodwill and in-process research and development (IPR&D) impairment analysis for fiscal 2013 and plans to record in fiscal 2013, a pre-tax, non-cash asset impairment charge of about $495 million.Primarily related to goodwill attributable to the company's acquisition of American Medical Systems.Says during the fourth quarter of 2013, it also recorded a pre-tax, non-cash charge of about $316 million, to increase the company's product liability reserve to about $520 million for all known, pending and estimated future claims.Says non-cash charges will not affect the company's fiscal 2013 adjusted financial results; however, fiscal 2013 reported (GAAP) earnings per share are now expected to be materially below previously announced guidance of $0.95 to $1.10. 

Company Quote

84.14
 --
1 Jun 2015